The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy

被引:18
|
作者
Shi, Ting-Ting [1 ]
Hua, Lin [2 ]
Wang, Hua [3 ]
Xin, Zhong [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Capital Med Univ, Sch Biomed Engn, Dept Math, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing, Peoples R China
关键词
OPHTHALMOPATHY; MANAGEMENT; IMMUNITY; CELLS;
D O I
10.1155/2019/9736968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective. A previous study reported alterations in the intestinal microbiota in patients with Graves' orbitopathy (GO). Thyrotropin receptor autoantibody (TRAb) stimulates orbital and periorbital tissues and plays a pivotal role in the development of GO. However, the association between gut microbiota and TRAb in GO patients has still remained elusive. In this study, we explored the relationships between gut microbiota and GO-related traits, in which we applied a metabolic-network-driven analysis to identify GO trait-related modules and extracted significant operational taxonomic units (OTUs). Methods. In the present study, we profiled gut microbiota using 16S rRNA gene sequencing in 31 GO patients. We performed metabolic-network-driven analysis to investigate the association between gut microbiota and GO-related traits (e.g., TRAb, TGAb, and TPOAb) in the combination of microbial effects. Results. Applying microbiome network analysis of cooccurrence patterns and analysis of topological properties, we found that s_Prevotella_copri and f_Prevotellaceae showed a significant correlation with TRAb. In particular, we applied the latent class model to explore the association between gut microbiota and GO-related traits in the combination of microbial effects. It was revealed that the subjects involved in the latent class model with the higher abundance of s_Prevotella_copri and g_Bacteroides had a higher TRAb level. Conclusions. Our results revealed the potential relationships between gut microbiota and GO-related traits in the combination of microbial effects. This study may provide a new insight into the interaction between the intestinal microbiota and TRAb-associated immune responses in GO patients.
引用
收藏
页数:12
相关论文
共 49 条
  • [1] Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study
    Shi, T. -T.
    Xin, Z.
    Hua, L.
    Zhao, R. -X.
    Yang, Y. -L.
    Wang, H.
    Zhang, S.
    Liu, W.
    Xie, R. -R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (08) : 967 - 978
  • [2] Changes in the gut microbiota of patients with Graves' orbitopathy according to severity grade
    Zhang, Qianshi
    Tong, Boding
    Xie, Zhaoyu
    Li, Yunping
    Li, Yuan
    Wang, Lujue
    Luo, Ban
    Qi, Xin
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (08): : 808 - 821
  • [3] Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study
    T.-T. Shi
    Z. Xin
    L. Hua
    R.-X. Zhao
    Y.-L. Yang
    H. Wang
    S. Zhang
    W. Liu
    R.-R. Xie
    Journal of Endocrinological Investigation, 2019, 42 : 967 - 978
  • [4] Integrated Proteomics and Metabolomics Analyses of Serum in Chinese Patients with Severe and Active Graves' Orbitopathy: A Cross-sectional Study
    Shi, Ting-Ting
    Liu, Hong-Ying
    Zhu, Xiao-Rong
    Xin, Zhong
    Hua, Lin
    Xie, Rong-Rong
    Sun, Ran
    Cao, Xi
    Yang, Jin- Kui
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (09) : 1151 - 1161
  • [5] Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease
    Chen, J.
    Wang, W.
    Guo, Z.
    Huang, S.
    Lei, H.
    Zang, P.
    Lu, B.
    Shao, J.
    Gu, P.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (09) : 1913 - 1926
  • [6] Associations between gut microbiota and thyroidal function status in Chinese patients with Graves’ disease
    J. Chen
    W. Wang
    Z. Guo
    S. Huang
    H. Lei
    P. Zang
    B. Lu
    J. Shao
    P. Gu
    Journal of Endocrinological Investigation, 2021, 44 : 1913 - 1926
  • [7] Potential risk factor of Graves' orbitopathy among Chinese patients: A clinical investigation
    Zhou, Yuan-Ting
    Ren, Guo-Qin
    Wu, Fu-Ping
    Jiang, Jia
    Yang, Ying-Hua
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (05): : 2296 - 2300
  • [8] Misfortunes do not come in pairs in patients with active moderate-to-severe Graves' orbitopathy
    Sawicka-Gutaj, Nadia
    Gruszczynski, Dawid
    Zawalna, Natalia
    Nijakowski, Kacper
    Fichna, Marta
    Ruchala, Marek
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (06):
  • [9] Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy
    Bartalena, Luigi
    Wiersinga, Wilmar M.
    EUROPEAN THYROID JOURNAL, 2020, 9 (SUPPL 1) : 3 - 16
  • [10] Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
    Campi, Irene
    Vannucchi, Guia
    Muller, Ilaria
    Lazzaroni, Elisa
    Curro, Nicola
    Dainese, Martina
    Montacchini, Benedetta
    Covelli, Danila
    Guastella, Claudio
    Pignataro, Lorenzo
    Fugazzola, Laura
    Arosio, Maura
    Salvi, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12